Pharma Capital
Showing 40 of 40
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £46.18m £0.34 -2.90% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £22.64m £0.31 16.98% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £11.51m £1.30 0.00% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £161.90m £0.27 -1.80% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £232.85m £0.49 -0.51% ico_glass.png
amryt-pharma.jpg Amryt Pharmaceuticals AIM £45.83m £0.22 -5.88% ico_glass.png
angle-logo.png ANGLE plc AIM £39.28m £0.53 3.96% ico_glass.png
avacta.png Avacta Group Plc AIM £55.74m £0.82 1.88% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £41.30m £0.91 0.00% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £967.42m £8.41 3.38% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £19.46m £0.06 20.00% ico_glass.png
concepta.png Concepta AIM £17.27m £0.16 2.44% ico_glass.png
constellation-logo.png Constellation Healthcare Technologies, Inc. AIM £- £- - ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £11.87m £0.04 0.00% ico_glass.png
E--therapeutics-logo.png e-Therapeutics plc AIM £22.15m £0.08 1.54% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £80.40m £1.99 -0.50% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £178.19m £6.43 3.88% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £61.52m £0.51 0.00% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £7.94m £0.43 0.00% ico_glass.png
Horizon-logo.2.png Horizon Discovery Group PLC AIM £201.45m £2.10 5.54% ico_glass.png
imm.gif ImmuPharma PLC AIM £70.24m £0.53 0.00% ico_glass.png
MaxCyte.gif MaxCyte AIM £123.00m £2.83 1.80% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £57.22m £1.18 -1.26% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £78.84m £0.40 -3.01% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £28.60m £0.56 0.00% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £57.14m £0.73 0.34% ico_glass.png
redx-logo.png Redx Pharma Plc AIM £41.11m £0.33 -4.76% ico_glass.png
reneuron_logo.png ReNeuron Group Plc AIM £70.41m £0.02 0.00% ico_glass.png
rex_bionics_logo.png Rex Bionics PLC AIM £1.66m £0.07 0.00% ico_glass.png
sar.jpg Sareum Holdings Plc AIM £23.15m £0.01 -2.78% ico_glass.png
scancell.gif Scancell Holdings Plc AIM £34.33m £0.13 -2.78% ico_glass.png
silence-logo-2.jpg Silence Therapeutics plc AIM £59.32m £0.85 -0.88% ico_glass.png
sphere_medical_sponsor_logo.gif Sphere Medical Holding PLC AIM £8.86m £0.06 -3.85% ico_glass.png
summit_corp_logo.png Summit Therapeutics PLC AIM £109.77m £1.78 0.00% ico_glass.png
synairgen-latest.jpg Synairgen plc AIM £23.75m £0.26 0.00% ico_glass.png
tissue_regenix_sponsor_logo.png Tissue Regenix Group PLC AIM £121.83m £0.16 1.59% ico_glass.png
Valirx-logo.png ValiRx Plc AIM £3.33m £0.03 -1.96% ico_glass.png
Venn-life-logo.png Venn Life Sciences Holdings plc AIM £10.17m £0.17 0.00% ico_glass.png
WideCellsGroup-2.jpg WideCells Group LSE £6.82m £0.13 0.00% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.